Aperol spritz have gained a reputation of being a healthier alternative to other cocktails. However, the drink contains sugar ...

Exercise is not only a blanket recommendation for optimal health; its an effective drug-free therapy capable of reversing ...

Background: Non-alcoholic-steatohepatitis (NASH) leading to fibrosis, end-stage cirrhosis and hepatocellular carcinoma is an increasing health problem in the Western world. Thus, the need for new ...

Up to 59.1% patients enrolled in the study achieved metabolic dysfunction-associated steatohepatitis resolution without ...

Altimmune stock took a huge hit after its liver disease drug, pemvidutide, failed to show strong results in reducing fibrosis ...

Altimmune said on Thursday its experimental obesity drug met the main goal of a mid-stage trial studying it as a potential treatment for a fatty liver disease. The drug, pemvidutide, showed a ...

Doctors report a rising number of cirrhosis cases in people who don’t drink alcohol. Poor diet, obesity, and a sedentary lifestyle are major causes. Experts warn early detection and lifestyle changes ...

The non-alcoholic steatohepatitis (NASH) clinical trials market is estimated to generate a market size of USD 2.96 billion in ...

Fatty liver disease is a common health issue. It is often linked to weight and lifestyle. Early detection is key to prevent ...

Inventiva S.A. (NASDAQ:IVA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. Analyst Edward Nash ...